Literature DB >> 6542864

Effect on heart rate over 24 hours of pindolol administered for 14 days.

J P Kantelip, J F Trolese, P G Cromarias, P Duchêne-Marullaz.   

Abstract

The effect on heart rate of pindolol 5, 15 and 30 mg/day, a beta-adrenoreceptor blocker possessing intrinsic sympathomimetic activity, administered to 8 healthy volunteers for 14 days was studied. Heart rate was continuously recorded over 24 h during placebo treatment before each sequence, every 2 days during treatment, and then on the 15th, 17th and 18th days. Pindolol in the three doses used had no significant effect on mean heart rate over 24 h. It tended to lower mean diurnal heart rate non-significantly between noon and 6 p.m. Pindolol raised nocturnal heart rate between midnight and 6 a.m. to a comparable extent at all the doses used. Sympathetic tone is at its lowest during that period, which makes it possible to detect the intrinsic sympathomimetic activity of pindolol. After cessation of treatment, a rebound effect was observed, cardioacceleration being most marked after 30 mg/day.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542864     DOI: 10.1007/bf00556888

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

Review 1.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  Treatment of hypertension with a beta-adrenoceptor blocker. A multicentre trial with pindolol.

Authors:  J Rosenthal; H Kaiser; A Raschig; D Welzel
Journal:  Br J Clin Pract       Date:  1979-06

Review 3.  The beta-adrenergic blockade withdrawal phenomenon.

Authors:  R J Walden; B Tomlinson; P Bhattacharjee; B N Prichard
Journal:  J Pharmacol       Date:  1983

4.  The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.

Authors:  R J Walden; P Bhattacharjee; B Tomlinson; J Cashin; B R Graham; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.

Authors:  R E Rangno; S Langlois
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 6.  Beta-adrenoceptor-blocking agents: are pharmacologic differences relevant?

Authors:  B J Clark
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

7.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

8.  Chronotropic effects of pindolol. Relation between ventricular effects and control resting ventricular rate values in conscious dogs with chronic A-V block.

Authors:  M Boucher; C Dubray; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

9.  Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.

Authors:  R C Hill; P Turner
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

10.  Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease.

Authors:  M Brodsky; D Wu; P Denes; C Kanakis; K M Rosen
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

View more
  2 in total

1.  Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

Authors:  J M Rapola; T J Pellinen; P Koskinen; L Toivonen; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.

Authors:  Shirin S Joseph; James A Lynham; Peter Molenaar; Andrew A Grace; William H Colledge; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-08       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.